NCT00264147View on ClinicalTrials.gov

Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)

PHASE2CompletedINTERVENTIONAL
Enrollment

761

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Rheumatoid Arthritis
Interventions
DRUG

etoricoxib

Period I: Arm 1: etoricoxib 10 mg tablet once daily. 12 weeks of treatment.

DRUG

etoricoxib

Period I: Arm 2: etoricoxib 30 mg tablet once daily. 12 weeks of treatment.

DRUG

etoricoxib

Period I: Arm 3: etoricoxib 60 mg tablet once daily. 12 weeks of treatment.

DRUG

etoricoxib

Period I: Arm 4: etoricoxib 90 mg tablet once daily. 12 weeks of treatment.

DRUG

Comparator: placebo

Period I: Arm 5: Pbo tablet once daily. 12 weeks of treatment.

DRUG

etoricoxib

Period II: Arm 1: etoricoxib 90 mg tablet once daily. 12 weeks of treatment.

DRUG

Comparator: diclofenac

Period II: Arm 2: diclofenac 75 mg tablet twice daily. 12 weeks of treatment.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00264147 - Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED) | Biotech Hunter | Biotech Hunter